A detailed history of Nissay Asset Management Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Nissay Asset Management Corp holds 2,481 shares of BIO stock, worth $812,453. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,481
Previous 2,418 2.61%
Holding current value
$812,453
Previous $660,000 25.76%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $16,630 - $21,712
63 Added 2.61%
2,481 $830,000
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $28,167 - $35,645
-105 Reduced 4.16%
2,418 $660,000
Q1 2024

May 15, 2024

BUY
$304.11 - $351.99 $13,380 - $15,487
44 Added 1.77%
2,523 $872,000
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $19,125 - $25,917
71 Added 2.95%
2,479 $800,000
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $28,720 - $34,655
82 Added 3.53%
2,408 $863,000
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $25,164 - $34,048
-70 Reduced 2.92%
2,326 $881,000
Q1 2023

May 15, 2023

SELL
$418.69 - $503.0 $35,169 - $42,252
-84 Reduced 3.39%
2,396 $1.15 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $19,344 - $25,080
-55 Reduced 2.17%
2,480 $1.04 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $42,909 - $58,579
104 Added 4.28%
2,535 $1.06 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $16,692 - $21,497
36 Added 1.5%
2,431 $1.2 Million
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $36,719 - $51,479
70 Added 3.01%
2,395 $1.35 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $7,797 - $8,741
11 Added 0.48%
2,325 $1.76 Million
Q3 2021

Nov 10, 2021

BUY
$657.71 - $825.77 $62,482 - $78,448
95 Added 4.28%
2,314 $1.73 Million
Q2 2021

Aug 13, 2021

SELL
$576.64 - $649.04 $80,152 - $90,216
-139 Reduced 5.89%
2,219 $1.43 Million
Q1 2021

May 11, 2021

SELL
$547.01 - $662.35 $20,786 - $25,169
-38 Reduced 1.59%
2,358 $1.35 Million
Q4 2020

Feb 08, 2021

BUY
$510.68 - $643.45 $13,277 - $16,729
26 Added 1.1%
2,396 $1.4 Million
Q3 2020

Oct 20, 2020

BUY
$454.43 - $535.6 $11,815 - $13,925
26 Added 1.11%
2,370 $1.22 Million
Q2 2020

Jul 27, 2020

BUY
$334.87 - $493.06 $81,708 - $120,306
244 Added 11.62%
2,344 $1.06 Million
Q1 2020

May 05, 2020

BUY
$320.01 - $409.07 $26,240 - $33,543
82 Added 4.06%
2,100 $736,000
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $645,215 - $755,135
2,018 New
2,018 $747,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.07B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.